Javier Szwarcberg

Chief Executive Officer at SPRUCE BIOSCIENCES, INC.

Net worth: 55 592 $ as of 2024-06-29

54 year

Health Technology

Consumer Services

Javier Szwarcberg active positions

Companies	Position	Start	End
SPRUCE BIOSCIENCES, INC.	Director/Board Member	2022-01-02	-
SPRUCE BIOSCIENCES, INC.	Chief Executive Officer	2022-01-02	-

Companies	Position	Start	End
BIOMARIN PHARMACEUTICAL INC.	Corporate Officer/Principal	2020-01-31	2021-12-31
ULTRAGENYX PHARMACEUTICAL INC.	Corporate Officer/Principal	2017-09-30	2020-01-31
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY	Chief Tech/Sci/R&D Officer	2016-09-30	2017-09-30

Universidad de Buenos Aires	Doctorate Degree
Harvard T.H. Chan School of Public Health	Graduate Degree

International

Operational

Corporate Officer/Principal	2
Director/Board Member	1
Chief Executive Officer	1

Sectoral

Health Technology	5
Consumer Services	3

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	3
SPRUCE BIOSCIENCES, INC.	Health Technology
BIOMARIN PHARMACEUTICAL INC.	Health Technology
ULTRAGENYX PHARMACEUTICAL INC.	Health Technology

Private companies	1
Horizon Therapeutics Plc Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.	Health Technology

Private companies

Health Technology